26 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

The SAM point of care diagnostics market is expected to grow from US$ 1,406.72 million in 2021 to US$ 2,973.02 million by 2028; it is estimated to grow at a CAGR of 11.3% from 2021 to 2028. The increasing number of CLIA-waived POC tests is expected to fuel the market growth.POC testing can be performed outside of a laboratory and is...

  • Point Of Care Testing
  • Brazil
  • Argentina
  • Drug Approval
  • Laboratory Revenue

The North America point of care diagnostics market is expected to grow from US$ 16,612.40 million in 2021 to US$ 38,702.11 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing product launches and product developments is to drive the market growth.The number of point-of-care testing has steadily...

  • Point Of Care Testing
  • North America
  • Drug Approval
  • Laboratory Revenue

INTRODUCTION According to the World Health Organization (WHO), the big three infectious diseases, namely human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS), malaria and tuberculosis (TB), are reported to be the cause of approximately 2.5 million annual fatalities worldwide. , , , Moreover, the...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Infectious Disease Incidence

The MEA point of care diagnostics market is expected to grow from US$ 2,484.03 million in 2021 to US$ 5,433.77 million by 2028; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028. Rising number of conferences and events is expected to surge the market growth.Various conferences and events are held to make people aware about...

  • Point Of Care Testing
  • South Africa
  • Saudi Arabia
  • Diabetes Prevalence
  • Laboratory Revenue

The APAC point of care diagnostics market is expected to grow from US$ 6,548.48 million in 2021 to US$ 15,641.78 million by 2028; it is estimated to grow at a CAGR of 13.2% from 2021 to 2028. The growing use of home-based poc devices is expected to surge the market.The increasing awareness about point of care testing is bringing the...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • APAC
  • Diabetes Prevalence
  • Cancer Incidence

The Europe point of care diagnostics market is expected to grow from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028. Rising prevalence of infectious diseases is expected to fuel the market growth.Point-of-care testing (POCT) plays a critical role in diagnosis,...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • Europe
  • Drug Approval
  • Laboratory Revenue

African Trypanosomiasis (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Drugs In Development, 2021, provides an overview of the African Trypanosomiasis (Infectious Disease) pipeline landscape. African...

  • Infectious Disease
  • Drug Development
  • Africa
  • Drug Approval
  • Rural Population

African Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Drugs In Development, 2022, provides an overview of the African Trypanosomiasis (Infectious...

  • Infectious Disease
  • Africa
  • Drug Approval
  • Health Provider Density

The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where...

  • Point Of Care Testing
  • World
  • North America
  • United States
  • India
  • APAC
  • HIV AIDS Prevalence
  • Chronic Disease Prevalence

The point of care diagnostics market was valued at US$ 36,000.4 million in 2021 and is projected to reach US$ 82,958.3 million by 2028; it is expected to grow at a CAGR of 12.7% from 2021 to 2028. The market growth is primarily attributed to increase in prevalence of infectious diseases, product developments and launches, and rise in number...

  • Point Of Care Testing
  • World
  • Cancer Incidence
  • Diabetes Prevalence

The ASEAN and North Asian Point of Care/Rapid Diagnostics market size is expected to grow from an estimated USD 2.0 billion in 2021 to USD 3.9 billion by 2026, at a CAGR of 13.0%. The growing demand for accurate and early diagnostic methodologies, modernization and expansion of healthcare infrastructure and significant disease prevalence are...

  • Diagnostics
  • Asia
  • ASEAN
  • Health Expenditure
  • Gross Domestic Expenditure On R&D

Point of Care POC Infectious Disease Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Point of Care POC Infectious Disease Diagnostics...

  • Infectious Disease
  • Diagnostics
  • Managed Care
  • APAC
  • Central America

African Trypanosomiasis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Pipeline Review, H2 2020, provides an overview of the African Trypanosomiasis (Infectious Disease) pipeline landscape. African trypanosomiasis...

  • Infectious Disease
  • Africa
  • Rural Population

Point Of Care (PoC) Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Point Of Care (PoC) Diagnostics market including the COVID-19...

  • Diagnostics
  • Managed Care
  • APAC
  • Central America

Cleanroom Technology Market Research Report: By Type (Consumables, Equipment), Construction (Standard, Hardwall, Softwall, Pass-Through), End-Use Industry (Pharmaceutical, Biotechnology, Medical Device) - Global Industry Analysis and Growth Forecast to 2030 The global cleanroom technology market attained a value of...

  • Infectious Disease
  • Marketing Research
  • Pharmaceutical
  • Medical Device
  • Biopharmaceutical
  • World
  • Infectious Disease Incidence

Global Gastrointestinal Partnering 2015 to 2022 provides the full collection of Gastrointestinal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gastrointestinal...

  • Digestive System Disorder
  • World

North America ultra-low temperature freezer market is anticipated to reach US$ 313.19 million in 2027 from US$ 220.25 million in 2019. The market is projected to grow with a CAGR of 4.7% from 2019 to 2027. The growth of the North America ultra-low temperature freezer market is primarily attributed to the rising demand for blood and blood...

  • Biotechnology
  • Pharmaceutical
  • Infectious Disease
  • North America
  • Freezer Sales
  • Energy Consumption

Global Pediatrics Partnering 2010 to 2022 provides the full collection of Pediatrics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Pediatrics partnering deals Financial deal terms for headline, upfront and royalty by stage of development Pediatrics partnering...

  • Hospital
  • World

African Trypanosomiasis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide African Trypanosomiasis - Pipeline Review, H1 2020, provides an overview of the African Trypanosomiasis (Infectious Disease) pipeline landscape. African trypanosomiasis...

  • Infectious Disease
  • Africa
  • Rural Population

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Pipeline Review, H1 2020, provides an overview of the Chagas Disease (Infectious Disease) pipeline landscape. Chagas disease or...

  • Autoimmune Disease
  • United States
  • Prescription Drug Sales
  • Medical Technology Density

The global plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021, growing at a CAGR of 12.9 % from 2021 to 2028. Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market’s growth. However, the potential risk of...

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate

Summary NOWDiagnostics Inc (NOWDiagnostics) is a medical diagnostic company.The company manufactures and sells blood-based rapid tests. The company offers COVID-19 test, acetaminophen test, hCG test, H-FABP test, methanol dip test, salicylate test, troponin I test, myoglobin test, in home HIV test, and others.NOWDiagnostics’...

  • Diagnostics
  • Clinical Trial
  • World
  • Europe
  • Italy
  • Medical Devices Sales

Summary AnteoTech Ltd (AnteoTech) formerly Anteo Diagnostics Ltd is a leading medical technology company that develops and commercializes healthcare products.The company along with its subsidiaries is a provider of immunoassays, in-vitro diagnostics, and point of care (PoC) tests to entities involved in the life sciences,...

  • Infectious Disease
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Clinical Trial
  • Managed Care
  • United States
  • Medical Devices Sales

Summary QuantuMDx Group Ltd (QuantuMDx) operates as a developer of sciences tools and diagnostics products.The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases,...

  • Infectious Disease
  • Diagnostics
  • Hospital
  • Gene Therapy
  • World
  • Cervical Cancer Screening Coverage
  • Prescriptions Filled

Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and supplies in vitro diagnostic medical devices.The portfolio of companys products include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. It offers expertise...

  • Infectious Disease
  • Diagnostics
  • Clinical Trial
  • United Kingdom
  • Senegal
  • United States
  • West Africa
  • Hospital Admission
  • Medical Devices Sales